CSCO

Cisco Systems, Inc.

NMS · Technology

$118.39

$3.50 (+3.05%)up 3.05%

12 October 2026 · delayed 15+ min

C-

Quality score71.7 / 100

Cut-offs are the grader's own: 97+ for an A+, below 60 is an F.

Cisco Systems, Inc. earns a C- on excellent profit margins (>20%) and strong ROE (>20%) but current ratio below 1.0 (liquidity concerns) and high debt-to-equity ratio (>2.0). Reasonable investment with moderate upside potential.

Model stance HOLD Suggested position 6.0% · $600.00 IQInvest estimate
Adjusted for Moderate investors, Medium-term investors 6.0% suggested allocation Change these

These change the suggested position size and the stance, not the category scores. Amount is in dollars.

IQ-CSCO-20261012engine v1 · 7-category weighted scorecard

What it is worth, depending who you ask.

Today’s price against the year it has had and the targets analysts publish. Every marker is a reported figure, not a projection of ours.

52-week low

$66.81

Lowest analyst target

$110.00

Today's price

$118.39

52-week high

$130.37

Mean analyst target

$136.16

Highest analyst target

$170.00

CSCO trades 81% of the way up its 52-week range, between $66.81 and $130.37. The mean analyst target of $136.16 is 15.0% above today's price.

Today’s price 52-week range Analyst price targets

Scored categories

Financial healthExcellent profit margins (>20%); Strong ROE (>20%); Current ratio below 1.0 (liquidity concerns); High debt-to-equity ratio (>2.0) 85.023%

Profit margin

20.95%

Net profit per unit of revenue

exceptionalWhat this means

Of every 100 units of revenue, this much survives as profit.

Margins this wide usually mean real pricing power or a moat.

Operating margin

27.72%

Before interest and tax

very highWhat this means

Profit from operations, before interest and tax, per 100 of revenue.

Typical of software and other businesses with little cost per extra sale.

Gross margin

64.52%

After the cost of goods only

highWhat this means

What is left of revenue after only the direct cost of the product.

Little marginal cost per sale, which is what lets software and pharma fund heavy R&D.

Return on equity

27.32%

Profit per unit of shareholder capital

very strongWhat this means

Profit generated per unit of shareholder capital.

Rare when sustained — check whether debt is flattering it, since borrowing shrinks the equity denominator.

Return on assets

7.98%

Profit per unit of assets

strongWhat this means

Profit generated per unit of everything the company owns.

The assets are working hard.

Debt to equity

62.02

Borrowings against equity

moderateWhat this means

Borrowings measured against shareholder capital.

Normal for most established companies.

Current ratio

0.93

Short-term assets over short-term debts

tightWhat this means

Short-term assets against short-term obligations.

Below 1 the company owes more within a year than it holds — workable if customers pay up front, risky otherwise.

Quick ratio

0.69

As above, excluding inventory

adequateWhat this means

Short-term assets excluding inventory, against short-term debts.

Near-term obligations are roughly covered without selling inventory.

Revenue growth

17.60%

Year on year

growingWhat this means

Change in revenue against the same period last year.

A healthy expansion rate.

Earnings growth

52.10%

Year on year

very strongWhat this means

Change in earnings against the same period last year.

Check whether it is repeatable or a one-off — a single asset sale can flatter this badly.

Revenue

$63.33B

Trailing twelve months

Free cash flow

$11.18B

Cash left after capital spending

Operating cash flow

$14.18B

Cash from the business itself

Payout ratio

49.85%

Dividends as a share of earnings

highWhat this means

The share of earnings paid out as dividends.

Most of the profit goes out of the door, leaving less to reinvest.

Growth & momentumStrong 1-year return (72.4%) 90.022%

Return, 1 month

5.99%

Return, 3 months

1.50%

Return, 6 months

44.86%

Return, year to date

57.73%

Return, 1 year

72.36%

Return, 3 years

140.66%

Sharpe ratio

0.75

Return earned per unit of risk

modestWhat this means

Return earned per unit of risk taken.

Below 1 is the common case; return did not strongly outpace the volatility.

Win rate

53.11%

Share of days that closed up

consistently positiveWhat this means

The share of trading days that closed higher.

More up days than most shares manage.

Average daily return

0.09%

Best day

13.41%

Worst day

-13.73%

ValuationHigh P/E ratio (35.6) - may be overvalued; High P/B ratio (9.29) 20.018%

P/E ratio

35.55

Price against trailing earnings

highWhat this means

You pay 35.55 for every 1 unit of annual earnings.

Above about 25 the market is paying up for expected growth.

Forward P/E

21.06

Price against forecast earnings

moderateWhat this means

Price against next year's *forecast* earnings.

A conventional range.

PEG ratio

1.09

P/E adjusted for growth

fairWhat this means

P/E divided by the growth rate — it asks whether the price is justified by the growth.

Between 1 and 2 price and growth are roughly in step.

Price to book

9.29

Price against balance-sheet equity

well above bookWhat this means

Price against the accounting value of the company's net assets.

Normal for asset-light businesses, where the value sits in brands and software the balance sheet never records.

Price to sales

7.37

Price against revenue

highWhat this means

Price against revenue — usable when a company has no profit yet.

The price assumes today's revenue will convert into much more profit later.

EV / EBITDA

25.86

Whole-company value against cash earnings

highWhat this means

Whole-company value, debt included, against cash earnings.

Expensive even before interest, tax and depreciation are considered.

Enterprise value

$482.03B

Market value plus debt, minus cash — the price of the whole business

Shares outstanding

3,942,586,873

Shares the profit is split across

Dividend yield

1.42%

Annual dividend against price

modestWhat this means

Annual dividend as a percentage of the share price.

A small income component.

TechnicalPrice well above 200-day SMA (strong uptrend); Strong trend (ADX > 25) 100.015%

RSI (14)

65.2

Above 70 overbought, below 30 oversold

neutralWhat this means

A 0–100 momentum gauge over the last 14 sessions.

The middle band, where most trading days sit.

MACD

1.56

Momentum against its own trend

MACD histogram

1.33

Positive is bullish

ADX

26.3

Trend strength; above 25 is a real trend

trendingWhat this means

Trend strength, regardless of direction.

Above 25 is conventionally read as a genuine trend in force.

20-day average

$110.17

50-day average

$111.94

200-day average

$97.95

Price vs 50-day

5.76%

Price vs 200-day

20.87%

Bollinger upper

$118.26

Bollinger lower

$102.09

Average true range

2.79

Typical daily trading range

Stochastic %K

98.2

RiskModerate beta (market-like risk) 40.012%

Volatility, annualised

26.06%

How far it swings in a year

normalWhat this means

How far the price typically swings over a year.

A typical range for an individual share.

Beta

0.98

Moves against the wider market

market-likeWhat this means

How much the price moves relative to the wider market.

Moves roughly in step with the index.

Maximum drawdown

-36.68%

Worst peak-to-trough fall

significantWhat this means

The worst peak-to-trough fall in the period measured.

A serious decline, though not unusual over a multi-year window.

Risk category

High

The engine's own banding

Analyst viewAnalyst consensus: Buy; Strong analyst coverage (25 analysts) 90.010%

Consensus

Buy

What covering analysts rate it

Analysts covering

25

Mean price target

$136.16

Highest target

$170.00

Lowest target

$110.00

Implied upside

15.01%

Target against today's price

meaningfulWhat this means

How far the mean analyst target sits above today's price.

Analysts see real room above today's price.

Price against the S&P 500

180 trading days to 2026-10-09

CSCO is 60.8% up over the window, against 13.0% up for the S&P 500 — ahead by 47.8 points.
CSCO +60.8%S&P 500 +13.0%
Show the numbers
Sampled across the window. Both columns are rebased to 100 on 2026-01-23, so they can be compared directly.
DateCloseCSCO rebasedS&P 500 rebased
2026-01-23$73.63100.0100.0
2026-02-13$75.86103.098.9
2026-03-09$75.23102.298.3
2026-03-30$76.04103.391.7
2026-04-21$89.02120.9102.1
2026-05-12$98.54133.8107.0
2026-06-03$125.54170.5109.2
2026-06-25$118.07160.4106.4
2026-07-17$111.51151.5107.8
2026-08-07$120.96164.3112.2
2026-08-28$109.51148.7111.5
2026-09-21$111.03150.8112.3

How the score was built

Each category is scored 0–100, then multiplied by its weight. The seven contributions sum to the quality score.
CategoryScoreWeightContribution
Financial health85.023%19.6
Growth & momentum90.022%19.8
Valuation20.018%3.6
Technical100.015%15.0
Risk40.012%4.8
Analyst view90.010%9.0
ESG50.00%0.0
Quality score100%71.8

ESG is scored but carries no weight in this grade. Add ?esg=1 to the address to include it — the engine then redistributes weight across the other six, so the whole scorecard changes, not just one row.

Argue with the model

Every other grader hands you a number. This one hands you the model.

Move a slider, press Recalculate, and the grade is rebuilt from the same category scores. Nothing is hidden: the scores are the engine's, only the weighting is yours.

What each model believes. Pick one above, or set your own sliders below.
ModelThe emphasis
IQInvest defaultThe engine's own weighting: financial health 23% and performance 22% lead, valuation 18%, then technicals, risk and analysts.
Value investorPrice against worth dominates: valuation 40%, financial health 25%. Chart signals count for almost nothing.
Growth investorMomentum first: performance 40% and technicals 20%. Whether the price is fair today gets just 5%.
Sleep at nightStability over everything: risk 35% and financial health 30% together outweigh all other categories combined.
ChartistThe tape over the fundamentals: technicals 45% and performance 25%. Valuation is nearly ignored.
18%
23%
22%
12%
15%
10%
0%

These are IQInvest's own weights, totalling 100%.

Your grade

C-

71.8 / 100

Identical to the IQInvest grade.

All 66 metricsOne flat sortable table, for when you want everything at once.
Metric Category Value Source
20-day averageTechnical$110.17Yahoo Finance
200-day averageTechnical$97.95Yahoo Finance
50-day averageTechnical$111.94Yahoo Finance
52-week highMarket data$130.37Yahoo Finance
52-week lowMarket data$66.81Yahoo Finance
ADXTechnical26.3Yahoo Finance
Analysts coveringAnalyst view25Yahoo Finance
Average daily returnGrowth & momentum0.09%Yahoo Finance
Average true rangeTechnical2.79Yahoo Finance
Average volumeMarket data19,205,120Yahoo Finance
Best dayGrowth & momentum13.41%Yahoo Finance
BetaRisk0.98Yahoo Finance
Bollinger lowerTechnical$102.09Yahoo Finance
Bollinger upperTechnical$118.26Yahoo Finance
ConsensusAnalyst viewBuyYahoo Finance
Current ratioFinancial health0.93Yahoo Finance
Day highMarket data$118.65Yahoo Finance
Day lowMarket data$115.36Yahoo Finance
Debt to equityFinancial health62.02Yahoo Finance
Dividend yieldValuation1.42%Yahoo Finance
Earnings growthFinancial health52.10%Yahoo Finance
EmployeesMarket data82,400Yahoo Finance
Enterprise valueValuation$482.03BYahoo Finance
EV / EBITDAValuation25.86Yahoo Finance
Forward P/EValuation21.06Yahoo Finance
Free cash flowFinancial health$11.18BYahoo Finance
Gross marginFinancial health64.52%Yahoo Finance
Highest targetAnalyst view$170.00Yahoo Finance
Implied upsideAnalyst view15.01%Yahoo Finance
Lowest targetAnalyst view$110.00Yahoo Finance
MACDTechnical1.56Yahoo Finance
MACD histogramTechnical1.33Yahoo Finance
Maximum drawdownRisk-36.68%Yahoo Finance
Mean price targetAnalyst view$136.16Yahoo Finance
OpenMarket data$116.77Yahoo Finance
Operating cash flowFinancial health$14.18BYahoo Finance
Operating marginFinancial health27.72%Yahoo Finance
P/E ratioValuation35.55Yahoo Finance
Payout ratioFinancial health49.85%Yahoo Finance
PEG ratioValuation1.09Yahoo Finance
Previous closeMarket data$114.89Yahoo Finance
Price to bookValuation9.29Yahoo Finance
Price to salesValuation7.37Yahoo Finance
Price vs 200-dayTechnical20.87%Yahoo Finance
Price vs 50-dayTechnical5.76%Yahoo Finance
Profit marginFinancial health20.95%Yahoo Finance
Quick ratioFinancial health0.69Yahoo Finance
Return on assetsFinancial health7.98%Yahoo Finance
Return on equityFinancial health27.32%Yahoo Finance
Return, 1 monthGrowth & momentum5.99%Yahoo Finance
Return, 1 yearGrowth & momentum72.36%Yahoo Finance
Return, 3 monthsGrowth & momentum1.50%Yahoo Finance
Return, 3 yearsGrowth & momentum140.66%Yahoo Finance
Return, 6 monthsGrowth & momentum44.86%Yahoo Finance
Return, year to dateGrowth & momentum57.73%Yahoo Finance
RevenueFinancial health$63.33BYahoo Finance
Revenue growthFinancial health17.60%Yahoo Finance
Risk categoryRiskHighYahoo Finance
RSI (14)Technical65.2Yahoo Finance
Shares outstandingValuation3,942,586,873Yahoo Finance
Sharpe ratioGrowth & momentum0.75Yahoo Finance
Stochastic %KTechnical98.2Yahoo Finance
Volatility, annualisedRisk26.06%Yahoo Finance
VolumeMarket data11,422,038Yahoo Finance
Win rateGrowth & momentum53.11%Yahoo Finance
Worst dayGrowth & momentum-13.73%Yahoo Finance
Add to portfolio Compare Peers Set a price target

Yahoo Finance via yfinance · delayed 15 minutes or more